On the eve of Prime Minister Ana Brnabic's visit to Moscow, the agreements were signed by Minister without Portfolio in charge of Innovation and Technological Development and President of the Intergovernmental Committee for Cooperation with Russia Nenad Popovic and Rosatom Overseas President Evgeny Pakermanov.
Under these agreements, during the next three years, the Centre for Nuclear Medicine based on a cyclotron complex and facilities for the production of radiopharmaceuticals will be built in Serbia.
Popovic pointed out that this is a historic day in the relations between Serbia and Russia, because the mentioned agreements return Serbia to the map of European countries that have capacity for scientific research in the field of nuclear technologies.
As he pointed out, this will increase Serbia's preparedness in the field of medicine, science, research, and we already have requests from the surrounding countries to use the capacities of this centre together with our scientists.
Director-General of the State Corporation “Rosatom” Alexey Likhachev explained that the Radiopharmaceutical Complex and the Centre for Nuclear Medicine will make high-tech medical care accessible to the citizens of Serbia, aimed primarily at solving problems in the fight against oncological diseases.
Pakermanov added that within the joint venture with the Serbian side, modern production of radiopharmaceuticals for the diagnosis and treatment of various diseases will be launched.
This will significantly contribute to the development of advanced nuclear medicine in Serbia and in the entire region, he pointed out, adding that the start of work for the practical implementation of the project is planned for 2022.